![Entinostat, a novel histone deacetylase inhibitor is active in B-cell lymphoma and enhances the anti-tumour activity of rituximab and chemotherapy agents]()
Entinostat, a novel histone deacetylase inhibitor is active in B-cell lymphoma and enhances the anti-tumour activity of rituximab and chemotherapy agentsFrys, Sarah; Simons, Zachary; Hu, Qiang; Barth, Matthew J.; Gu, Juan J.; Mavis, Cory; Skitzki, Joseph; Song, Liu; Czuczman, Myron S.; Hernandez-Ilizaliturri, Francisco J. · British Journal of Haematology · 2015